AirFit™ F30

Ultra-compact full face mask

Ultra-compact mask delivering full face functionality in a smaller, quieter, less obtrusive format than traditional ResMed masks.1 The under-the-nose design of the AirFit F30 increases visual and physical freedom and eliminates problems with discomfort and facial marking on the nasal bridge.
Product codes: S standard elbow (64114), M standard elbow (64115), S QuietAir elbow (64110), M QuietAir elbow (64111)

Less is more

The ultra-compact AirFit F30 mask allows you to reach a broader population. The under-the-nose design eliminates issues associated with discomfort and facial marking on the nasal bridge and is particularly suitable for patients with claustrophobia or sensitive skin.

The F30 is also a solution for patients who want to wear glasses or read during therapy.

Peaceful relaxation

The AirFit F30 features the same innovative QuietAir™ vent as the AirFit F20 high-performance mask, gently diffusing exhaled air to limit noise and create a relaxing environment in the bedroom.

Streamlined operations

You can achieve fast and effective fitting2 with just one frame, one headgear and two cushion sizes. This streamlined setup simplifies stock management and logistics.
Accurate first-time fit helps to reduce callbacks and refits.

Interactive 20 & 30 series brochure

CPAP-masks-interactive-brochure-for-healthcare-professionals-ResMed

Interested in the bigger picture? Check out our 20 & 30 series interactive brochure.

Buy online

ResMed Online Store is the one-stop-shop for sleep professionals, with immediate access to pricing, shipping and invoice details. Contact your ResMed representative to create an account or sign in to start buying and tracking ResMed products.

Warranty & services

Looking for service and warranty information on the ResMed AirFit F30 ultra-compact full face mask?
Find the answers to your questions in our resource centre.

 

References:

  1. Sound power level with QuietAir of 21 dBA –  AirFit F30 user guide, ResMed Pty Ltd 2019. ID A4500405.
  2. ResMed external 7-day clinical study of 21 ResMed and non-ResMed patients, conducted between 16/04/2018 – 05/05/2018. Data on file; ID A4356449.